PAVmed- Warrants (29/01/2022) Operating Income

As of the most recent data (June 2026), PAVMW shows a operating income of $-13B. That compares with $-22B in the prior-year period — up 40.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PAVMW's operating income is now $-13B (was $-22B) — a 40.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether PAVmed- Warrants (29/01/2022) is outperforming or lagging.

Tracking PAVMW's operating income over time shows whether PAVmed- Warrants (29/01/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $-13B That compares with $-22B in the prior-year period — up 40.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has PAVmed- Warrants (29/01/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-13B) with ownership activity and broader fundamentals.

PAVmed- Warrants (29/01/2022)'s operating income is $-13B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.